Preparation method of N-2-hydroxypropyl trimethyl ammonium chloride chitosan/N, O-carboxymethyl chitosan newcastle disease attenuated live vaccine nanoparticle
A technology of hydroxypropyltrimethylammonium chloride and carboxymethyl chitosan, which is applied in antiviral agents, viral antigen components, freeze-dried transportation, etc., can solve the problems of chitosan application limitations and achieve good biological Adhesiveness, uniform particle size distribution, and low drug side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0017] Specific embodiment one: present embodiment N-2-hydroxypropyltrimethylammonium chloride chitosan / N, the preparation method of O-carboxymethyl chitosan Newcastle disease live attenuated vaccine nanoparticle, according to the following steps accomplish:
[0018] 1. Take 5mL of N-2-hydroxypropyltrimethylammonium chloride chitosan solution with a concentration of 0.5-20mg / mL, and then add 1.25-7.5mL of Newcastle disease L-series virus solution dropwise to it, and stir magnetically for 3min , to obtain solution A;
[0019] 2. Solution A is magnetically stirred at 900-1300r / min for 10-40min at room temperature and under sterile conditions, and then 2mL of N,O-carboxymethyl chitosan solution with a concentration of 0.5-3.0mg / mL is added dropwise to obtain a solution B;
[0020] 3. Centrifuge solution B at 4°C and 12000r / min for 2min, take the precipitate and wash it three times with deionized water, then vacuum freeze-dry for 24h to obtain N-2-hydroxypropyltrimethylammonium...
specific Embodiment approach 2
[0028]Specific embodiment two: the difference between this embodiment and specific embodiment one is that getting 5mL concentration in step one is the N-2-hydroxypropyltrimethylammonium chloride chitosan solution of 1mg / mL, then to wherein dropwise 2mL Newcastle disease L-series virus solution. Other steps and parameters are the same as those in Embodiment 1.
specific Embodiment approach 3
[0029] Specific embodiment 3: The difference between this embodiment and specific embodiment 1 is that in step 2, solution A is magnetically stirred at 1200 r / min for 30 min at room temperature and under sterile conditions, and then 2 mL of N with a concentration of 1 mg / mL is added dropwise. carboxymethyl chitosan solution. Other steps and parameters are the same as those in Embodiment 1.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
